In the Field
How a clinical trial is run, how its data is shared, and what post-trial responsibilities the sponsors have to clinical trial participants varies depending on the country, industry and therapeutic area of that trial (among other things). These are the issues discussed at regular brainstorming sessions hosted by the Multi-Regional Clinical Trials (MRCT) Center.
There are some bizarre and improbable correlations that show two unlikely variables have a positive relationship. How do scientists then know when a relationship they find in the laboratory is factual?
In this guest piece, Matthew Herder of Dalhousie University in Nova Scotia, Canada shares a template letter that physicians, researchers, civil society groups, investigative journalists and others can use to gain access to unpublished pharmaceutical safety and effectiveness data.